Atlas Trials

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3

Clinical trial NCT04277338 · COMPLETED

Trial details

NCT number
NCT04277338
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Primary Breast Cancer
Start date
2020-02-10
Primary completion
2021-02-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.